{
  "catalogId": "b689fa56-0340-45c8-8cd9-4fc9bf1947d6",
  "name": "TECARTUS",
  "status": "draft",
  "category": "prescription",
  "registrationValidity": "valid",
  "registrationNumber": "168 50 36655 00",
  "treatmentDescriptions": "Acute Lymphoblastic Leukaemia Tecartus is indicated for the treatment of adult patients with relapsed or refractory B-cell precursor acute lymphoblastic leukaemia (ALL).Mantle Cell Lymphoma Tecartus is indicated for the treatment of adult patients with relapsed or refractory mantle cell lymphoma (MCL) after two or more lines of systemic therapy including a Bruton's tyrosine kinase (BTK) inhibitor unless ineligible to BTK inhibitor •Limitation of Use : TECARTUS is not indicated for the treatment of patients with active central nervous system lymphoma",
  "termsOfIssue": "Prescription required",
  "form": "dispersion for infusion",
  "route": "i.v",
  "site": "",
  "method": "",
  "administrationNotes": "",
  "ingredients": "ANTI-CD19 CAR T CELLS 0.4-2x10^8 CELLS/ BAG",
  "codes": {},
  "contraindications": "",
  "sideEffect": "",
  "warnings": "תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת",
  "alternativeMedications": [],
  "packaging": [
    {
      "name": "TECARTUS",
      "manufacturer": {
        "name": "גיליאד",
        "countryOfOrigin": "IL"
      },
      "strength": [],
      "quantity": {
        "value": 1.0,
        "unit": "units"
      },
      "packagingDescription": "CRYOGENIC BAG POLYOLEFINE",
      "shelfLife": "12",
      "storageConditions": "",
      "codes": {
        "moh": "8804",
        "yarpa": "80264"
      },
      "manufacturersAdministrationRecommendation": "",
      "pricing": {
        "currency": "ILS",
        "maxWholesalePrice": 1309117.303,
        "retailMargin": 10.0,
        "maxRetailPrice": 1440029.034,
        "maxPriceWithVAT": 1699234.184
      },
      "formulation": ""
    }
  ],
  "metadata": {
    "version": "1.5",
    "lastUpdated": "2025-08-01T18:03:51.212835"
  }
}